NUT Midline Carcinoma

Madam – NUT midline carcinoma (NMC) is a rare, recently discovered, genetically defined, highly aggressive cancer [1]. Because of its rarity, few data are available regarding incidence, risk factors, indication, outcomes and sequencing of treatment modalities. Hence, we decided to audit data of individu al patients diagnosed as NMC (defined on the basis of NUT-1 antibody positivity status on immunohistochemistry) in our institute between 2015 and 2018.

Source: Clinical Oncology - July 18, 2019 Category: Radiology Authors: V.M. Patil, A. Toshniwal, V. Noronha, A. Joshi, N. Menon, S. Banavali, K. Prabhash Tags: Letter Source Type: research